Evaluation of PSA Patterns in Patients With Localized Prostate Cancer Treated With Radiation Therapy and Androgen Deprivation Therapy

被引：0
|
作者：
Yang, T. [1 ]
Pei, X. [1 ]
Zhang, Z. [1 ]
Kollmeier, M. [1 ]
Spratt, D. [1 ]
Zumsteg, Z. [1 ]
Polkinghorn, W. [1 ]
McBride, S. [1 ]
Zelefsky, M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1353
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2545
引用
收藏
页码：S428 / S428
页数：1
相关论文
共 50 条
  • [11] Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy
    Deka, Rishi
    Rose, Brent S.
    Bryant, Alex K.
    Sarkar, Reith R.
    Nalawade, Vinit
    McKay, Rana
    Murphy, James D.
    Simpson, Daniel R.
    CANCER, 2019, 125 (07) : 1070 - 1080
  • [12] Treatment timing in localized high-risk prostate cancer treated with radiation and androgen deprivation therapy
    Hasan, Shaakir
    Lazarev, Stanislav
    Gorovets, Daniel
    Garg, Madhur
    Press, Robert H.
    Choi, Isabelle
    Simone, Charles B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [13] Neo-adjuvant androgen deprivation therapy prior to radiation therapy in localized prostate cancer
    Ludgate, CM
    Lim, JTW
    BRITISH JOURNAL OF CANCER, 1996, 74 : 26 - 26
  • [14] Optimizing androgen deprivation therapy with radiation therapy for aggressive localized and locally advanced prostate cancer
    Yang, David D.
    Nguyen, Paul L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 720 - 727
  • [15] Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy
    Atsushi Tomioka
    Nobumichi Tanaka
    Motokiyo Yoshikawa
    Makito Miyake
    Satoshi Anai
    Yoshitomo Chihara
    Eijiro Okajima
    Akihide Hirayama
    Yoshihiko Hirao
    Kiyohide Fujimoto
    BMC Cancer, 15
  • [16] Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy
    Tomioka, Atsushi
    Tanaka, Nobumichi
    Yoshikawa, Motokiyo
    Miyake, Makito
    Anai, Satoshi
    Chihara, Yoshitomo
    Okajima, Eijiro
    Hirayama, Akihide
    Hirao, Yoshihiko
    Fujimoto, Kiyohide
    BMC CANCER, 2015, 15
  • [17] Androgen and prostate cancer: the role of primary androgen deprivation therapy in localized prostate cancer
    Namiki, Mikio
    Kitagawa, Yasuhide
    Mizokami, Atsushi
    Koh, Eitetsu
    JOURNAL OF MENS HEALTH, 2008, 5 (04) : 333 - 341
  • [18] Duration of Androgen Deprivation Therapy based on Nadir PSA in High Risk Localized Prostate Cancer
    Ayoub, Z.
    Khader, J.
    Bulbul, M.
    Khauli, R.
    Andraos, T.
    Shamseddine, A.
    Mukherji, D.
    Geara, F.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S23 - S23
  • [19] Intensity modulated radiation therapy reduces gastrointestinal morbidity in patients treated with androgen deprivation therapy for prostate cancer
    Sharma, N. K.
    Li, T.
    Horwitz, E. M.
    Pollack, A.
    Buyyounouski, M. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S10 - S10
  • [20] Need for Androgen Deprivation Therapy in Addition to Definitive Radiation Therapy in Patients With Intermediate-Risk Localized Prostate Cancer
    Ghadjar, Pirus
    Boehmer, Dirk
    Hoecht, Stefan
    Sedlmayer, Felix
    Wiegel, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15) : 1746 - +
12345